DRUG DEVELOPMENT CONSULTING

How to make the solid decisions

CRS’ highly qualified medical and scientific experts provide knowledge and expertise in drug development accumulated over more than 40 years. This allows CRS to guide a New Molecular Entity (NME) fast and efficiently along the whole early phase drug development value chain.

This in turn supports CRS‘ customers to reach a fast Proof-of-Concept (POC) and to get all relevant information to make the right strategic decisions.

CRS creates a reliable ground for robust decisions

All this in combination is precisely what creates a reliable ground for solid decisions regarding the advanced phases of clinical research that are yet to come.

CRS’ full spectrum services

CRS as your early phase Contract Research Organization (CRO) provides a full spectrum of services, which include:

  • Consulting in clinical pharmacology
  • Consulting in core indication specification
    • Cardiometabolic
    • Women’s health
    • Dermatology
    • etc.
  • Support in the preparation of Scientific Advise Meetings at competent authorities and participation in it
  • Placement of Key Opinion Leaders (KOL)
  • Creation of the Development Plan

REACHING OUT IS EASY AND FAST – LET’S TALK

Dr. Marc Hetzel

VP & Head of Business Development
located at CRS Management


LET’S TALK BUSINESS

BACK TO OVERVIEW

CRO Leadership Awards 2019

CRS is proud to be recognised again by pharma companies worldwide as a leading CRO with regard to: capabilities, compatibility, quality and reliability.

European Biotechnology Guide

Find CRS’s company profile in the European Biotechnology Science Industry Guide, volume 9 2019.

EcoVadis – CSR Rating

Based on the CSR rating by EcoVadis in July 2018 CRS has been granted Silver Recognition Level.